The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats

TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy

(2013) Anna Baumgarten et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Inhibition of xanthine oxidase reduces wasting and improves outcome in a rat model of cancer cachexia

(2012) Jochen Springer et al.   INTERNATIONAL JOURNAL OF CANCER

Serum Concentrations of Myostatin and Myostatin-Interacting Proteins Do Not Differ Between Young and Sarcopenic Elderly Men

(2011) A. Ratkevicius et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

In search of new therapeutic targets and strategies for heart failure: recent advances in basic science

(2011) Ajay M Shah et al.   LANCET

The ACT-ONE trial, a multicentre, randomised, double-blind, placebo-controlled, dose-finding study of the anabolic/catabolic transforming agent, MT-102 in subjects with cachexia related to stage III and IV non-small cell lung cancer and colorectal cancer:

(2011) Andrew J. Stewart Coats et al.   Journal of Cachexia Sarcopenia and Muscle

IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia

(2011) Katja Schmidt et al.   Journal of Cachexia Sarcopenia and Muscle

The role of myostatin in muscle wasting: an overview

(2011) Yulia Elkina et al.   Journal of Cachexia Sarcopenia and Muscle

Targeting the myostatin signaling pathway to treat muscle wasting diseases

(2011) H.Q. Han et al.   Current Opinion in Supportive and Palliative Care

Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival

(2010) Xiaolan Zhou et al.   CELL

Functional consequences of sarcopenia and dynapenia in the elderly

(2010) Brian C Clark et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Changes in growth-related kinases in head, neck and limb muscles with age

(2010) Jill A. Rahnert et al.   EXPERIMENTAL GERONTOLOGY

Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function

(2010) Kate T. Murphy et al.   FASEB JOURNAL

Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training

(2010) Karsten Lenk et al.   Journal of Cachexia Sarcopenia and Muscle

An overview of sarcopenia: facts and numbers on prevalence and clinical impact

(2010) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

The influence of age and sex on disease development in a novel animal model of cardiac cachexia

(2009) Sandra Palus et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Sarcopenia: etiology, clinical consequences, intervention, and assessment

(2009) T. Lang et al.   OSTEOPOROSIS INTERNATIONAL

No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure

(2008) Yoshihiro J. Akashi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Sarcopenia: Diagnosis and treatment

(2008) J. E. Morley   Journal of Nutrition Health & Aging

Heme Oxygenase-Mediated Increases in Adiponectin Decrease Fat Content and Inflammatory Cytokines Tumor Necrosis Factor-  and Interleukin-6 in Zucker Rats and Reduce Adipogenesis in Human Mesenchymal Stem Cells

(2008) D. H. Kim et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS